Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

An Enhanced Actualized DNP Model to Improve DNP Project Placements, Rigor, and Completion.

VanderKooi ME, Conrad DM, Spoelstra SL.

Nurs Educ Perspect. 2018 Sep/Oct;39(5):299-301. doi: 10.1097/01.NEP.0000000000000384.

2.

Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols.

Liwski RS, Greenshields AL, Conrad DM, Murphey C, Bray RA, Neumann J, Gebel HM.

Hum Immunol. 2018 Jan;79(1):28-38. doi: 10.1016/j.humimm.2017.10.020. Epub 2017 Nov 9.

PMID:
29109009
3.

Mixed phenotype acute leukemia, B/myeloid, NOS with near-tetraploidy: a case report.

Nix KM, Harrison KJ, Shivakumar SP, Shawwa AA, Conrad DM.

Int J Clin Exp Pathol. 2017 Nov 1;10(11):11206-11210. eCollection 2017.

4.

Process mining is an underutilized clinical research tool in transfusion medicine.

Quinn JG, Conrad DM, Cheng CK.

Transfusion. 2017 Mar;57(3):501-503. doi: 10.1111/trf.13995. Epub 2017 Feb 5.

PMID:
28164303
5.

A re-examination of the role of the acute phase protein response in innate cancer defence.

Conrad DM, Hoskin DW, Liwski R, Naugler C.

Med Hypotheses. 2016 Aug;93:93-6. doi: 10.1016/j.mehy.2016.05.025. Epub 2016 May 24.

PMID:
27372864
6.

A case of congenital TTP presenting with microganiopathy in adulthood.

Gallivan CD, Conrad DM, Kew AK.

BMC Hematol. 2014 Sep 12;14(1):16. doi: 10.1186/2052-1839-14-16. eCollection 2014.

7.

Pleurocidin-family cationic antimicrobial peptides mediate lysis of multiple myeloma cells and impair the growth of multiple myeloma xenografts.

Hilchie AL, Conrad DM, Coombs MR, Zemlak T, Doucette CD, Liwski RS, Hoskin DW.

Leuk Lymphoma. 2013 Oct;54(10):2255-62. doi: 10.3109/10428194.2013.770847. Epub 2013 Mar 4.

PMID:
23350892
8.

Induction of CD4(+)CD25(+)Foxp3(-) regulatory T cells by Thy-1 stimulation of CD4(+) T cells.

Conrad DM, Coombs MR, Furlong SJ, Forward NA, Hoskin DW.

Immunol Cell Biol. 2012 Feb;90(2):248-52. doi: 10.1038/icb.2011.33. Epub 2011 Apr 26.

PMID:
21519344
9.

Curcumin blocks interleukin (IL)-2 signaling in T-lymphocytes by inhibiting IL-2 synthesis, CD25 expression, and IL-2 receptor signaling.

Forward NA, Conrad DM, Power Coombs MR, Doucette CD, Furlong SJ, Lin TJ, Hoskin DW.

Biochem Biophys Res Commun. 2011 Apr 22;407(4):801-6. doi: 10.1016/j.bbrc.2011.03.103. Epub 2011 Apr 2.

PMID:
21443863
10.

Extensive neurocristic hamartoma with bone marrow involvement.

Conrad DM, Chaplin A, Walsh NM, Pasternak S.

Am J Dermatopathol. 2010 Jul;32(5):486-8. doi: 10.1097/DAD.0b013e3181c3422b.

PMID:
20414093
11.

Primary cutaneous PEComa.

Chaplin A, Conrad DM, Tatlidil C, Jollimore J, Walsh N, Covert A, Pasternak S.

Am J Dermatopathol. 2010 May;32(3):310-2. doi: 10.1097/DAD.0b013e3181b9e5c4.

PMID:
20139753
12.

The Ca(2+) channel blocker flunarizine induces caspase-10-dependent apoptosis in Jurkat T-leukemia cells.

Conrad DM, Furlong SJ, Doucette CD, West KA, Hoskin DW.

Apoptosis. 2010 May;15(5):597-607. doi: 10.1007/s10495-010-0454-3.

PMID:
20094800
13.

The hardscrabble hypothesis: a reduction in chronic tissue damage has increased the incidence of autoimmune disease.

Naugler C, Conrad DM.

Med Hypotheses. 2010 Feb;74(2):366-7. doi: 10.1016/j.mehy.2009.07.004. Epub 2009 Aug 4.

PMID:
19656638
14.

Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation.

Conrad DM, Furlong SJ, Doucette CD, Boudreau RT, Hoskin DW.

Cell Signal. 2009 Aug;21(8):1298-307. doi: 10.1016/j.cellsig.2009.03.014. Epub 2009 Mar 24.

PMID:
19324083
15.

Quantitative HLA-G expression in metastasising and non-metastasising primary thin cutaneous melanomas.

Bezuhly M, Howlett A, Colp P, Conrad DM, Walsh N, Rowden G, Morris SF, Langley RG.

Dermatology. 2008;217(3):281-3. doi: 10.1159/000150602. Epub 2008 Aug 7. No abstract available.

16.

2-Chloro-2'-deoxyadenosine-induced apoptosis in T leukemia cells is mediated via a caspase-3-dependent mitochondrial feedback amplification loop.

Conrad DM, Robichaud MR, Mader JS, Boudreau RT, Richardson AM, Giacomantonio CA, Hoskin DW.

Int J Oncol. 2008 Jun;32(6):1325-33.

PMID:
18497995
17.

Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).

Hoskin DW, Mader JS, Furlong SJ, Conrad DM, Blay J.

Int J Oncol. 2008 Mar;32(3):527-35. Review.

PMID:
18292929
18.
19.
20.

Adenosine-induced apoptosis in EL-4 thymoma cells is caspase-independent and mediated through a non-classical adenosine receptor.

El-Darahali A, Fawcett H, Mader JS, Conrad DM, Hoskin DW.

Exp Mol Pathol. 2005 Dec;79(3):249-58. Epub 2005 Sep 15.

PMID:
16168410
21.

Antibody blockade of Thy-1 (CD90) impairs mouse cytotoxic T lymphocyte induction by anti-CD3 monoclonal antibody.

Haeryfar SM, Conrad DM, Musgrave B, Hoskin DW.

Immunol Cell Biol. 2005 Aug;83(4):352-63.

PMID:
16033530
22.

Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines.

Mader JS, Salsman J, Conrad DM, Hoskin DW.

Mol Cancer Ther. 2005 Apr;4(4):612-24.

24.

Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling.

Conrad DM, Hanniman EA, Watson CL, Mader JS, Hoskin DW.

J Cell Biochem. 2004 May 15;92(2):387-99.

PMID:
15108363
25.

Risk assessment of first-degree relatives of women with breast cancer: a feasibility study.

Hurt GJ, McQuellon RP, Michielutte R, Conrad DM, Carter S, Anderson H.

Oncol Nurs Forum. 2001 Aug;28(7):1097-104.

PMID:
11517843

Supplemental Content

Loading ...
Support Center